BRIEF-Clover Biopharmaceuticals Updates On Bivalent COVID-19 Vaccine Candidate
May 5 (Reuters) - Clover Biopharmaceuticals Ltd : * BIVALENT COVID-19 VACCINE CANDIDATE DEMONSTR
抱歉,当前请求异常(-1)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial